No Data
No Data
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
IShares Genomics Immunology and Healthcare ETF Declares $0.1111 Dividend
Hedge Funds Were Net Buyers of Financials, Healthcare for Week: Goldman Sachs
Capitulation in Biotech Is Near, as Well as a Rally – Piper Sandler
Why Recursion Is Getting Love as an AI and Drug Discovery Top Pick
Inflation cooling solidifies the expectation of Fed rate cuts! Will this industry become the new darling of Wall Street?
The SPDR S&P Biotech ETF (XBI) has achieved five consecutive gains, with a cumulative increase of nearly 8% in 5 days.